Skip to main content

Table 5 Effects of epitopic missense variants on TNFA-infliximab interaction

From: Missense variants in the TNFA epitopes and their effects on interaction with therapeutic antibodies—in silico analysis

SNP_ID

Amino acid positiona

Amino acid change

∆∆G (Kcal/mol)b

Antibody chains

MutaBindb

PPcheck

mCSM-PPI2

SAAMBE-3D

MutaBind

∆∆G (kcal/mol)

Total stabilizing energy (kJ/mol)

WT

H

− 188.42

L

− 148.55

rs1427914441

70

P/S

0.669

1.05

0.6

H

1.18

− 180.87

L

0.31

− 148.18

rs758652888

73

H/Q

0.264

1.03

0.18

H

0.47

− 188.4

L

1.41

− 137.66

rs753130938

73

H/R

0.034

0.84

0.31

H

0.53

− 188.38

L

1.45

− 145.3

rs140654183

105

T/N

0.315

0.62

− 0.1

H

1.09

− 186.46

L

0.66

− 148.51

rs1473587140

110

E/K

0.491

1

0.17

H

1.18

− 184.14

L

0.63

− 148.55

rs770509340

138

R/Q

0.875

1.81

1.2

H

0.72

− 186.64

L

1.56

− 146.21

rs141307820

138

R/W

1.234

1.01

1.2

H

1.01

− 186.21

L

1.58

− 153.47

rs370893734

140

D/N

1.439

1.25

0.66

H

0.93

− 156.05

L

0.89

− 149.23

rs370893734

140

D/Y

0.398

0.6

2.03

H

1.28

− 160.89

L

1.29

− 158.06

rs763621932

141

Y/S

0.72

0.86

0.57

H

1.3

− 180.87

L

1.02

− 148.78

  1. aAmino acid positions were calculated excluding the signal peptide (76 amino acids)
  2. bPositive values of ∆∆G indicate decreasing affinity